These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 1895044
1. Antihypertensive efficacy and tolerability of enalapril and slow-release verapamil in essential hypertension: a double-blind, cross-over study. Fagher B, Katzman P, Hulthén UL, Henningsen NC, Thulin T. J Intern Med; 1991 Sep; 230(3):219-26. PubMed ID: 1895044 [Abstract] [Full Text] [Related]
2. Antihypertensive and renal effects of enalapril and slow-release verapamil in essential hypertension. A double-blind, randomized study. Fagher B, Henningsen N, Hulthén L, Katzman P, Thulin T. Eur J Clin Pharmacol; 1990 Sep; 39 Suppl 1():S41-3. PubMed ID: 2261943 [Abstract] [Full Text] [Related]
4. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising. White WB, Sica DA, Calhoun D, Mansoor GA, Anders RJ. Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162 [Abstract] [Full Text] [Related]
8. Efficacy and safety of a new long-acting drug combination, trandolapril/verapamil as compared to monotherapy in primary hypertension. Swedish TARKA trialists. Karlberg BE, Andrup M, Odén A. Blood Press; 2000 Oct; 9(2-3):140-5. PubMed ID: 10855738 [Abstract] [Full Text] [Related]
11. [Treatment of arterial hypertension in the aged subject with a converting enzyme inhibitor: enalapril]. Forette F, Handfield-Jones R, Henry-Amar M, Fouchard M, Bouchacourt P, Hervy MP, Henry JF, Mesguisch-Billaud E, Alexandre JM. Presse Med; 1985 Dec 19; 14(44):2237-41. PubMed ID: 3003729 [Abstract] [Full Text] [Related]
12. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group. Karlberg BE, Lins LE, Hermansson K. J Hypertens; 1999 Feb 19; 17(2):293-302. PubMed ID: 10067800 [Abstract] [Full Text] [Related]
13. A double blind comparative study of lisinopril and enalapril in patients with essential hypertension. Johnston GD, Banks DC, Davies S, Duffin D, Garnham JC, Nicholls DP, Raj MV, Mansy S, Sloan P, Strouthidis TM. J Hum Hypertens; 1991 Oct 19; 5(5):405-10. PubMed ID: 1663163 [Abstract] [Full Text] [Related]
15. Treatment of mild to moderate hypertension with or without the converting enzyme inhibitor enalapril. Results of a six-month double-blind trial. Sassano P, Chatellier G, Billaud E, Alhenc-Gelas F, Corvol P, Ménard J. Am J Med; 1987 Aug 19; 83(2):227-35. PubMed ID: 3039842 [Abstract] [Full Text] [Related]
16. Renal and endocrine effects of long-term converting enzyme inhibition as compared with calcium antagonism in essential hypertension. Katzman PL, Henningsen NC, Fagher B, Thulin T, Hulthén UL. J Cardiovasc Pharmacol; 1990 Mar 19; 15(3):360-4. PubMed ID: 1691357 [Abstract] [Full Text] [Related]
17. The efficacy and tolerability of enalapril in a formulation with a very low dose of hydrochlorothiazide in hypertensive patients resistent to enalapril monotherapy. Guul SJ, Os I, Jounela AJ. Am J Hypertens; 1995 Jul 19; 8(7):727-31. PubMed ID: 7546499 [Abstract] [Full Text] [Related]